PURE BioMedicine Q4 2025 Financial Report
NQ Score
60/100
N1 Content Completeness
7
AI Summary (NQ-processed)
PURE BioMedicine Co., Ltd. reported an operating revenue of 31 million NTD and a net loss of 453 million NTD for Q4 2025, resulting in a basic EPS of -7.23 NTD.
AI analysis data is not yet available.